A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

NCT01173601 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1416

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: Placebo
DRUG: SSRI

Sponsor

Eli Lilly and Company